Member News
![](https://i0.wp.com/investornews.com/wp-content/uploads/2023/11/Coeptis_Therapeutics_Holdings_Inc_lg.jpg?fit=900%2C230&ssl=1)
-
Coeptis Therapeutics President and CEO Issues Letter to Shareholders Highlighting 2023 Accomplishments and Outlook for 2024
January 4, 2024 (Source) — Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) (the “Company” or “Coeptis”), a biopharmaceutical company developing…
-
Ucore Acquires Alexandria, Louisiana, Facility for Rare Earth Element Processing Plant
January 4, 2024 (Source) — Ucore announces: The execution of a multi-decade lease for an 80,800 square foot…
-
NEO Battery Materials Completes Relocation to R&D Expansion Facility in Gyeonggi Technopark
January 03, 2024 (Source) — (TSXV: NBM) (OTCQB: NBMFF) Completed Relocation of R&D Scale-Up Centre to Gyeonggi Technopark Accommodates…
-
First Phosphate Closes Second Tranche of Oversubscribed Private Placement for Total Current Financing of $7.5 Million
January 2, 2024 (Source) — First Phosphate Corp. (CSE: PHOS) (OTC: FRSPF) (FSE: KD0) (“First Phosphate” or the “Company”)…
-
First Phosphate Closes Second Tranche of Oversubscribed Private Placement for Total Current Financing of $7.5 Million
December 29, 2023 (Source) — First Phosphate Corp. (CSE: PHOS) (OTC: FRSPF) (FSE: KD0) (“First Phosphate” or the…
-
Hemostemix Clarifies its October 3, 2023 News Release
December 29, 2023 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is…
-
Appia Rare Earths & Uranium – A Year in Review
President’s Letter to Stakeholders and Shareholders December 28, 2023 (Source) — Appia Rare Earths & Uranium Corp. (CSE: API)…